Skip to main content
Raymund Razonable, MD, Infectious Disease, Rochester, MN

RaymundRRazonableMD

Infectious Disease Rochester, MN

Professor, Internal Medicine, Mayo Medical School

Dr. Razonable is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Razonable's full profile

Already have an account?

Education & Training

  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Infectious Disease, 1999 - 2002
  • Icahn School of Medicine at Mount Sinai (Beth Israel)
    Icahn School of Medicine at Mount Sinai (Beth Israel)Residency, Internal Medicine, 1995 - 1999
  • Far Eastern University Nicanor Reyes Medical Foundation
    Far Eastern University Nicanor Reyes Medical FoundationClass of 1992
  • Far Eastern University
    Far Eastern UniversityB.S., Medical Technology, Graduate with honors, Cum Laude, 1984 - 1988

Certifications & Licensure

  • WI State Medical License
    WI State Medical License 2013 - 2025
  • MN State Medical License
    MN State Medical License 1999 - 2024
  • American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

  • Mayo Clinic Quality Fellow: Bronze Level Certification Mayo Clinic Quality Academy, 2012
  • Fellow Infectious Disease Society of America, 2011
  • Clinical Infectious Diseases Award for Outstanding Review 2010
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Definitions of Resistant and Refractory Cytomegalovirus Infection and Disease in Transplant Recipients for Use in Clinical Trials  
    Roy F Chemaly, Kathleen M Mullane, Robin Avery, Raymund R Razonable, Clinical Infectious Diseases
  • Fecal Microbiota Transplantation for Recurrent Clostridium Difficile Infection Reduces Recurrent Urinary Tract Infection Frequency  
    Raymund R Razonable, Pritish K Tosh, Randall C Walker, Clinical Infectious Diseases
  • Foreword to Guidelines 3  
    Blumberg EA, Danziger-Isakov L, Kumar D, Michaels MG, Razonable RR, Am J Transplant, 1/1/2013
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Studies of the epidemiology of infections in transplant patients and patients with impaired immunity due to underlying disease or immunosuppressive drugs.
    Beaird O, Freifeld A, Ison M, Lawrence S, Theodoropoulos M, Clark N, Razonable RR , Alangaden G, Waller S, Miller R, Smith J, Kaul D, ID Week, Philadelphia, PA, 10/8/2014
  • Cytomegalovirus (CMV) Disease is Associated with Higher Mortality after Lung Transplantation (LT) despite Extended Antiviral Prophylaxis.
    Beam E, Lesnick W, Kremers W, Razonable RR, ID Week, Philadelphia, PA, 10/8/2014
  • Association of Clostridium difficile Infection (CDI) with Excess Mortality after Liver Transplantation (LT) for Hilar Cholangiocarcinoma (CCA) (Poster Presentation).
    Ramanan P, Cummins NW, Wilhelm MP, Heimback JK, Dierkhising R, Kremers W, Rosen CB, Gores GJ, Razonable RR, ID Week, Philadelphia, PA, 10/8/2014
  • Join now to see all

Lectures

  • Infectious Complications of Liver Transplants 
    Chicago, IL - 9/1/2014
  • CMV in Solid Organ Transplantation 
    Rochester, MN - 2/1/2014
  • Biomarkers and Molecular Diagnostics in Transplant Infectious Diseases 
    Pleasanton, CA - 11/1/2013
  • Join now to see all

Other

  • A Review of Recent Research Updates in CMV. 
    Razonable RR, American Academy of CME Inc and Spire Learning
    4/15/2012
  • CMV infection in solid organ transplantation: Old questions, new answers. 
    Humar A, Kotton C, Razonable RR, Medscape
    http://cme.medscape.com
    1/1/2011
  • CMV disease in solid organ transplant recipients. eTransplant ID Review Podcast 
    Razonable RR
    http://www.hopkinscme.net/ofp/eTransplantIDReview/podcast/june2009_podcast_popup.html
    6/1/2009
  • Join now to see all

Press Mentions

  • New Coronavirus Variants Made the Last Remaining Monoclonal Antibody Drug Useless
    New Coronavirus Variants Made the Last Remaining Monoclonal Antibody Drug UselessDecember 3rd, 2022
  • IDSA Honors Notable Leaders in Infectious Diseases at ID
    IDSA Honors Notable Leaders in Infectious Diseases at IDOctober 19th, 2022
  • Bebtelovimab Appears Reliable for COVID-19 During Omicron Epoch
    Bebtelovimab Appears Reliable for COVID-19 During Omicron EpochSeptember 20th, 2022
  • Join now to see all